Status: The MediSieve Haemofiltration System has completed pre-clinical trials, and first-in-man safety studies are planned for 2020. The first trials will be focused on safety, performing the procedure on healthy human volunteers. Once these are completed, we will conduct follow-on clinical trials with malaria patients.
Status: The particles for sepsis are at in vitro demonstration stage. We are planning to start pre-clinical trials for sepsis in 2020.
Status: The particles for leukaemia are at in vitro demonstration stage.
*Programme Stage Key
1 - In vitro demonstration / 2 - Pre-clinical trials / 3 - Safety trials / 4 - Follow-on trials / 5 - Market
MediSieve expands its research into treating COVID-19
April 29, 2020
April 03, 2020